QA1.791

QA1.791: Familial cancer syndrome with pathogenic BRCA2 mutation

Billable / specific codeICD-10-CM

QA1.791 is a billable, specific ICD-10-CM code for familial cancer syndrome with pathogenic brca2 mutation. It is valid for submission on a claim.

Check QA1.791 with the rest of the claim: free scrubber

Inclusion terms

Alternative wordings a physician may use in the chart for this same code.

BRCA2-cancer predisposition syndrome
Hereditary breast and ovarian cancer syndrome with pathogenic BRCA2 mutation

Excludes2 inherited from the categories above QA1.791

Not part of this code, but both may be coded when both are present.

Written on QA1: Genetic disorders associated with neoplasms, not elsewhere classified

multiple endocrine neoplasia [MEN] syndromes (E31.2-)

Risk adjustment

No CMS-HCC V28 category: this code does not change a RAF score.

Medicare coverage

QA1.791 is named in 2 Medicare coverage policies: 2 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.

A56542Billing and Coding: BRCA1 and BRCA2 Genetic Testing
A57449Billing and Coding: BRCA1 and BRCA2 Genetic Testing

Alphabetic index entries that lead here

Syndrome›BRCA2-cancer predisposition
Syndrome›familial cancer›with›pathogenic BRCA2 mutation
Syndrome›hereditary breast and ovarian cancer›with›pathogenic BRCA2 mutation

Code history

addedFY2024-FY2027
Familial cancer syndrome with pathogenic BRCA2 mutation